Patient Capital Management’s Mattel MAT Stock Holding History
Bought
Maintained
Sold
Other funds holding MAT
EIG
VCM
VPM
AI
SAM
Patient Capital Management's MAT Position: Q1 2026 in Review
Patient Capital Management sold out of Mattel (MAT) in Q1 2026, closing a stake of 2,794,343 shares — an estimated $55.4M sold.
Patient Capital Management first reported a position in MAT in Q4 2021 and held it in 17 quarters. The position peaked at $77.6M in Q3 2023. 428 funds tracked by Wall St. Rank hold MAT as of Q1 2026.
- Patient Capital Management reported no remaining Mattel position as of Q1 2026 after selling out during the quarter.
- Patient Capital Management sold 2,794,343 Mattel shares in Q1 2026, an estimated $55.4M.
- Patient Capital Management first reported a position in Mattel in Q4 2021 and held it in 17 quarters.
- Patient Capital Management's Mattel position peaked at $77.6M in Q3 2023.
- 428 funds tracked by Wall St. Rank held Mattel as of Q1 2026.
Based on Patient Capital Management's 13F filing for Q1 2026, filed 14 May 2026.